|
T.V. Filippova, D.V. Svetlichnaya, V.I. Rudenko, Y.G. Alyaev, E.G. Tadevosyan, M.M. Azova, T.I. Subbotina, Z.K. Gadzhieva, A.Y. Asanov, K.R. Khamidullin, A.M. Pushkarev, M.M. Litvinova
Genetic aspects of primary hyperoxaluria: epidemiology, ethiology, pathogenesis, and clinical signs of the disorder
|
№6 / 2019
|
|
T.V. Filippova, D.V. Svetlichnaya, V.I. Rudenko, Y.G. Alyaev, M.V. Shumikhina, M.M. Azova, T.I. Subbotina, Z.K. Gadzhieva, A.Yu. Asanov, M.M. Litvinova
Genetic aspects of primary hyperoxaluria: diagnostics and treatment
|
№5 / 2019
|
|
A.G. Berezhnoy, F.A. Sevrukov, Yu.S. Vinnik, F.P. Kapsargin, Yu.Yu. Vinnik
Specific features of the immune status and blebbing of the plasmatic membrane of lymphocytes patients with urolithiasis complicated by the pyelonephritis
|
№5 / 2019
|
|
L.B. Kapanadze, V.I. Rudenko, N.S. Serova, L.M.Rapoport, K.A. Aleksandrova, A.A. Novikov
Dual-energy computed tomography in the diagnostics of urolithiasis
|
№5 / 2019
|
|
M.M. Kutluev, R.I. Safiullin
The impairment of the blood flow in renal parenchyma in patients with urinary stone disease after different treatment methods
|
№3 / 2019
|
|
V.S. Saenko, M.A. Gazimiev, S.V. Pesegov, Yu.G. Alyaev
Urinary stone disease. Part V. Drugs used for metaphylaxis of urinary stone disease
|
№3 / 2019
|
|
V.I. Rudenko, L.M. Rapoport, Yu.L. Demidko, L.S. Demidko, G.S. Inoyatov, S.N. Allenov
Clinical value of herbal terpenes after extracorporeal shock-wave therapy
|
№3 / 2019
|
|
V.S. Saenko, M.A. Gazimiev, S.V. Pesegov, Yu.G. Alyaev
Urinary stone disease. Part IV. Recurrence prevention for urinary stone disease
|
№2 / 2019
|
|
V.S. Saenko, M.A. Gazimiev, S.V. Pesegov, Yu.G. Alyaev
Methanaphylaxis of urolithiasis. Part 3. The factors associated with increase in incidence of urinary stone disease. Current views on the mechanisms of stone formation
|
№1 / 2019
|
|
M.Yu. Prosiannikov, E.K. Yanenko, S.K. Yarovoy, S.A. Golovanov, O.V. Konstantinova, N.V. Anokhin, O.V. Djalilov, A.V. Sivkov, O.I. Apolikhin
The features of pathogenesis of urolithiasis in patients with diabetes mellitus type 2
|
№1 / 2019
|
|
T.Kh. Nazarov, B.K. Komyakov, I.V. Rychkov, K.E. Trubnikova, A.I. Tursunov
Role of biomarkers of acute kidney damage during lithotripsy of high-density stones
|
№1 / 2019
|
|
V.S. Saenko, M.A. Gazimiev, S.V. Pesegov, Yu.G. Alyaev
Recurrence prevention for urinary stone disease. Part II.
The factors associated with increase in incidence of urinary stone disease. Current views on the mechanisms of stone formation (continuation)
|
№6 / 2018
|
Русский
